Susana
Ravassa Albéniz
Profesional Investigadora
University of Lorraine
Nancy, FranciaPublikationen in Zusammenarbeit mit Forschern von University of Lorraine (2)
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331